BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Brain cancer AND NUP214, ENSG00000126883, 8021, MGC104525, D9S46E, RP11-544A12_7, N214, CAIN, P35658, CAN AND Diagnosis
5885 results:

  • 1. Prognostic Implications of Small Cell Lung cancer Transcriptional Subtyping for CNS Metastases.
    Tringale KR; Skakodub A; Egger J; Eichholz J; Yu Y; Gomez D; Rimner A; Li B; Yamada Y; Wilcox J; Moss N; Imber BS; Rekhtman N; Baine MK; Rudin CM; Pike LRG
    JCO Precis Oncol; 2024 Apr; 8():e2300470. PubMed ID: 38691815
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. [Analysis of clinical manifestations and imaging features of facial nerve schwannomas].
    Han Y; Liu H; Yang R; Li R; Liu X; Wang W; Zhang J; Dong J; Zha D
    Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2024 May; 38(5):380-385. PubMed ID: 38686473
    [No Abstract]    [Full Text] [Related]  

  • 3. Germline biallelic BRCA2 pathogenic variants and medulloblastoma: an international cohort study.
    Kastellan S; Kalb R; Sajjad B; McReynolds LJ; Giri N; Samuel D; Milde T; Elbracht M; Holzhauer S; Niewisch MR; Kratz CP
    J Hematol Oncol; 2024 Apr; 17(1):26. PubMed ID: 38685107
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Association of Clinical, Tumor, and Treatment Characteristics With Seizure Control in Patients With
    Bruno F; Pellerino A; Conti Nibali M; Pronello E; Cofano F; Rossi M; Levis M; Bertero L; Soffietti R; Cassoni P; Garbossa D; Bello L; Rudà R
    Neurology; 2024 May; 102(10):e209352. PubMed ID: 38684041
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Radiological and Not Clinical Variables Guide the Surgical Plan in Patients with Glioblastoma.
    Martín-Abreu C; Fariña-Jerónimo H; Plata-Bello J
    Curr Oncol; 2024 Apr; 31(4):1899-1912. PubMed ID: 38668045
    [No Abstract]    [Full Text] [Related]  

  • 6. Clinical, pathologic, and genomic characteristics of two pediatric glioneuronal tumors with a CLIP2::MET fusion.
    Chapman N; Greenwald J; Suddock J; Xu D; Markowitz A; Humphrey M; Cotter JA; Krieger MD; Hawes D; Ji J
    Acta Neuropathol Commun; 2024 Apr; 12(1):63. PubMed ID: 38650040
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Imaging manifestations of papillary glioneuronal tumors.
    Du X; He Y; Li F; Wang X; Kong X; Ye M; Chen X
    Neurosurg Rev; 2024 Apr; 47(1):179. PubMed ID: 38649515
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. [Fully Automatic Glioma Segmentation Algorithm of Magnetic Resonance Imaging Based on 3D-UNet With More Global Contextual Feature Extraction: An Improvement on Insufficient Extraction of Global Features].
    Tian H; Wang Y; Ji Y; Rahman MM
    Sichuan Da Xue Xue Bao Yi Xue Ban; 2024 Mar; 55(2):447-454. PubMed ID: 38645864
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Design and methods of the mobile assessment of cognition, environment, and sleep (MACES) feasibility study in newly diagnosed breast cancer patients.
    Derbes R; Hakun J; Elbich D; Master L; Berenbaum S; Huang X; Buxton OM; Chang AM; Truica CI; Sturgeon KM
    Sci Rep; 2024 Apr; 14(1):8338. PubMed ID: 38594369
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. Real-life clinical management patterns in extensive-stage small cell lung cancer across France: a multi-method study.
    Mennecier B; Khalifa J; Descourt R; Greillier L; Naltet C; Falchero L
    BMC Cancer; 2024 Apr; 24(1):421. PubMed ID: 38580937
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. Prognostic utility and characteristics of MIB-1 labeling index as a proliferative activity marker in childhood low-grade glioma: a retrospective observational study.
    Gorodezki D; Zipfel J; Bevot A; Nägele T; Ebinger M; Schuhmann MU; Schittenhelm J
    J Cancer Res Clin Oncol; 2024 Apr; 150(4):178. PubMed ID: 38580878
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. Treatment modalities and outcomes of granular cell tumors and spindle cell oncocytomas of the pituitary gland: an analysis of two national cancer databases.
    Yohan Alexander A; Michalopoulos G; Kerezoudis P; Van Gompel JJ; Link MJ; Peris-Celda M
    Acta Neurochir (Wien); 2024 Apr; 166(1):169. PubMed ID: 38578465
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. Robust deep learning from incomplete annotation for accurate lung nodule detection.
    Gao Z; Guo Y; Wang G; Chen X; Cao X; Zhang C; An S; Xu F
    Comput Biol Med; 2024 May; 173():108361. PubMed ID: 38569236
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. Outcomes of 2-SSRS plus bevacizumab therapy strategy for brainstem metastases (BSM) over 2 cm
    Wang Z; Chen H; Chen Q; Zhu Y; Li M; Zhou J; Shi L
    Neurosurg Rev; 2024 Apr; 47(1):137. PubMed ID: 38564039
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. Intravascular large B-cell lymphoma of the eye: Literature review and new findings.
    Roditi E; Panicker S; Fung AT
    Asia Pac J Ophthalmol (Phila); 2024; 13(2):100053. PubMed ID: 38556129
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. Outcomes of the patients with metastatic male breast cancer.
    Dogan I; Khanmammadov N; Ozkurt S; Aydiner A; Saip P
    J Cancer Res Ther; 2024 Jan; 20(1):98-102. PubMed ID: 38554305
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. Clinical and biological landscape of constitutional mismatch-repair deficiency syndrome: an International Replication Repair Deficiency Consortium cohort study.
    Ercan AB; Aronson M; Fernandez NR; Chang Y; Levine A; Liu ZA; Negm L; Edwards M; Bianchi V; Stengs L; Chung J; Al-Battashi A; Reschke A; Lion A; Ahmad A; Lassaletta A; Reddy AT; Al-Darraji AF; Shah AC; Van Damme A; Bendel A; Rashid A; Margol AS; Kelly BL; Pencheva B; Heald B; Lemieux-Anglin B; Crooks B; Koschmann C; Gilpin C; Porter CC; Gass D; Samuel D; Ziegler DS; Blumenthal DT; Kuo DJ; Hamideh D; Basel D; Khuong-Quang DA; Stearns D; Opocher E; Carceller F; Baris Feldman H; Toledano H; Winer I; Scheers I; Fedorakova I; Su JM; Vengoechea J; Sterba J; Knipstein J; Hansford JR; Gonzales-Santos JR; Bhatia K; Bielamowicz KJ; Minhas K; Nichols KE; Cole KA; Penney L; Hjort MA; Sabel M; Gil-da-Costa MJ; Murray MJ; Miller M; Blundell ML; Massimino M; Al-Hussaini M; Al-Jadiry MF; Comito MA; Osborn M; Link MP; Zapotocky M; Ghalibafian M; Shaheen N; Mushtaq N; Waespe N; Hijiya N; Fuentes-Bolanos N; Ahmad O; Chamdine O; Roy P; Pichurin PN; Nyman P; Pearlman R; Auer RC; Sukumaran RK; Kebudi R; Dvir R; Raphael R; Elhasid R; McGee RB; Chami R; Noss R; Tanaka R; Raskin S; Sen S; Lindhorst S; Perreault S; Caspi S; Riaz S; Constantini S; Albert S; Chaleff S; Bielack S; Chiaravalli S; Cramer SL; Roy S; Cahn S; Penna S; Hamid SA; Ghafoor T; Imam U; Larouche V; Magimairajan Issai V; Foulkes WD; Lee YY; Nathan PC; Maruvka YE; Greer MC; Durno C; Shlien A; Ertl-Wagner B; Villani A; Malkin D; Hawkins C; Bouffet E; Das A; Tabori U
    Lancet Oncol; 2024 May; 25(5):668-682. PubMed ID: 38552658
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. Hsp70 and Calcitonin Receptor Protein in Extracellular Vesicles from Glioblastoma Multiforme: Biomarkers with Putative Roles in Carcinogenesis and Potential for Differentiating Tumor Types.
    Alberti G; Sánchez-López CM; Marcilla A; Barone R; Caruso Bavisotto C; Graziano F; Conway de Macario E; Macario AJL; Bucchieri F; Cappello F; Campanella C; Rappa F
    Int J Mol Sci; 2024 Mar; 25(6):. PubMed ID: 38542389
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. A systematic review of progranulin concentrations in biofluids in over 7,000 people-assessing the pathogenicity of GRN mutations and other influencing factors.
    Swift IJ; Rademakers R; Finch N; Baker M; Ghidoni R; Benussi L; Binetti G; Rossi G; Synofzik M; Wilke C; Mengel D; Graff C; Takada LT; Sánchez-Valle R; Antonell A; Galimberti D; Fenoglio C; Serpente M; Arcaro M; Schreiber S; Vielhaber S; Arndt P; Santana I; Almeida MR; Moreno F; Barandiaran M; Gabilondo A; Stubert J; Gómez-Tortosa E; Agüero P; Sainz MJ; Gohda T; Murakoshi M; Kamei N; Kittel-Schneider S; Reif A; Weigl J; Jian J; Liu C; Serrero G; Greither T; Theil G; Lohmann E; Gazzina S; Bagnoli S; Coppola G; Bruni A; Quante M; Kiess W; Hiemisch A; Jurkutat A; Block MS; Carlson AM; Bråthen G; Sando SB; Grøntvedt GR; Lauridsen C; Heslegrave A; Heller C; Abel E; Gómez-Núñez A; Puey R; Arighi A; Rotondo E; Jiskoot LC; Meeter LHH; Durães J; Lima M; Tábuas-Pereira M; Lemos J; Boeve B; Petersen RC; Dickson DW; Graff-Radford NR; LeBer I; Sellami L; Lamari F; Clot F; Borroni B; Cantoni V; Rivolta J; Lleó A; Fortea J; Alcolea D; Illán-Gala I; Andres-Cerezo L; Van Damme P; Clarimon J; Steinacker P; Feneberg E; Otto M; van der Ende EL; van Swieten JC; Seelaar H; Zetterberg H; Sogorb-Esteve A; Rohrer JD
    Alzheimers Res Ther; 2024 Mar; 16(1):66. PubMed ID: 38539243
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. REVOLUMAB: A phase II trial of nivolumab in recurrent IDH mutant high-grade gliomas.
    Picca A; Touat M; Belin L; Gourmelon C; Harlay V; Cuzzubbo S; Cohen-Jonathan Moyal E; Bronnimann C; Di Stefano AL; Laurent I; Lerond J; Carpentier C; Bielle F; Ducray F; Dehais C;
    Eur J Cancer; 2024 May; 202():114034. PubMed ID: 38537315
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 295.